193 related articles for article (PubMed ID: 31944877)
1. Dexmedetomidine: A Novel Strategy for Patients with Intractable Pain, Opioid-Induced Hyperalgesia, or Delirium at the End of Life.
Hofherr ML; Abrahm JL; Rickerson E
J Palliat Med; 2020 Nov; 23(11):1515-1517. PubMed ID: 31944877
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine use for patients in palliative care with intractable pain and delirium: A retrospective study.
Yu SY; Schellenberg J; Alleyne A
PLoS One; 2023; 18(9):e0292016. PubMed ID: 37756303
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine: a review of its use for the management of pain, agitation, and delirium in the intensive care unit.
Anger KE
Curr Pharm Des; 2013; 19(22):4003-13. PubMed ID: 23228319
[TBL] [Abstract][Full Text] [Related]
4. The effect of ketamine on delirium and opioid-induced hyperalgesia in the Intensive Care Unit.
Hayhurst CJ; Farrin E; Hughes CG
Anaesth Crit Care Pain Med; 2018 Dec; 37(6):525-527. PubMed ID: 30573208
[No Abstract] [Full Text] [Related]
5. Dexmedetomidine: a magic bullet on its way into palliative care-a narrative review and practice recommendations.
Gaertner J; Fusi-Schmidhauser T
Ann Palliat Med; 2022 Apr; 11(4):1491-1504. PubMed ID: 35400162
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine for hyperactive delirium at the end of life: An open-label single arm pilot study with dose escalation in adult patients admitted to an inpatient palliative care unit.
Thomas B; Lo WA; Nangati Z; Barclay G
Palliat Med; 2021 Apr; 35(4):729-737. PubMed ID: 33593115
[TBL] [Abstract][Full Text] [Related]
7. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.
Pandharipande PP; Pun BT; Herr DL; Maze M; Girard TD; Miller RR; Shintani AK; Thompson JL; Jackson JC; Deppen SA; Stiles RA; Dittus RS; Bernard GR; Ely EW
JAMA; 2007 Dec; 298(22):2644-53. PubMed ID: 18073360
[TBL] [Abstract][Full Text] [Related]
8. A case report of dexmedetomidine used to treat intractable pain and delirium in a tertiary palliative care unit.
Hilliard N; Brown S; Mitchinson S
Palliat Med; 2015 Mar; 29(3):278-81. PubMed ID: 25467740
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Quetiapine as a Sedative Adjunct in Mechanically Ventilated Adults Without Delirium.
Ohman KL; Schultheis JM; Kram SJ; Cox CE; Gilstrap DL; Yang Z; Kram BL
Ann Pharmacother; 2021 Feb; 55(2):149-156. PubMed ID: 32698609
[TBL] [Abstract][Full Text] [Related]
10. Pain, fentanyl consumption, and delirium in adolescents after scoliosis surgery: dexmedetomidine vs midazolam.
Aydogan MS; Korkmaz MF; Ozgül U; Erdogan MA; Yucel A; Karaman A; Togal T; Durmus M; Colak C
Paediatr Anaesth; 2013 May; 23(5):446-52. PubMed ID: 23448434
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine as an Option for Opioid Refractory Pain in the Hospice Setting.
Mupamombe CT; Luczkiewicz D; Kerr C
J Palliat Med; 2019 Nov; 22(11):1478-1481. PubMed ID: 31194614
[No Abstract] [Full Text] [Related]
12. Effects of dexmedetomidine on delirium duration of non-intubated ICU patients (4D trial): study protocol for a randomized trial.
Louis C; Godet T; Chanques G; Bourguignon N; Morand D; Pereira B; Constantin JM;
Trials; 2018 Jun; 19(1):307. PubMed ID: 29866205
[TBL] [Abstract][Full Text] [Related]
13. Sedation selection to reduce delirium risk: Why dexmedetomidine may be a better choice.
Mulkey MA; Everhart DE
J Am Assoc Nurse Pract; 2020 Jan; 33(4):266-270. PubMed ID: 31972787
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery.
Maldonado JR; Wysong A; van der Starre PJ; Block T; Miller C; Reitz BA
Psychosomatics; 2009; 50(3):206-17. PubMed ID: 19567759
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study).
Shehabi Y; Grant P; Wolfenden H; Hammond N; Bass F; Campbell M; Chen J
Anesthesiology; 2009 Nov; 111(5):1075-84. PubMed ID: 19786862
[TBL] [Abstract][Full Text] [Related]
16. Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine.
Szumita PM; Baroletti SA; Anger KE; Wechsler ME
Am J Health Syst Pharm; 2007 Jan; 64(1):37-44. PubMed ID: 17189578
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine (Precedex) for ICU sedation.
Med Lett Drugs Ther; 2011 May; 53(1365):41-2. PubMed ID: 21617592
[TBL] [Abstract][Full Text] [Related]
18. Effects of dexmedetomidine on delirium and mortality during sedation in ICU patients: a systematic review and meta-analysis protocol.
Sun R; Wang S; Li S; Yang C; Zhao Y; Luo A
BMJ Open; 2019 Apr; 9(4):e025850. PubMed ID: 30948590
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting.
Keating GM
Drugs; 2015 Jul; 75(10):1119-30. PubMed ID: 26063213
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary experience with dexmedetomidine treatment of confusional state and hyperadrenergic states at an intensive care unit].
Romero C; Bugedo G; Bruhn A; Mellado P; Hernández G; Castillo L
Rev Esp Anestesiol Reanim; 2002 Oct; 49(8):403-6. PubMed ID: 12455320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
